Medindia
Medindia LOGIN REGISTER
Advertisement

ChromaDex Reports Financial Results for the First Quarter 2011

Thursday, May 12, 2011 General News
Advertisement
Highlights include a 31% increase in revenue compared to first quarter 2010 and positive cash flow in the quarter

Condensed Consolidated Statements of Operations

Excluding Share-based Compensation (Non-GAAP Presentation)

Three Months Ended

April 2, 2011

April 3, 2010

Sales

$             2,539,245

$                      1,937,592

Cost of sales

1,518,850

1,119,619

Gross profit

1,020,395

817,973

Operating expenses:

Sales and marketing

445,507

224,619

General and administrative

985,815

502,434

1,431,322

727,053

Operating (loss) income

(410,927)

90,920

Nonoperating (income) expenses:

Interest expense

8,873

5,699

Interest income

(434)

(120)

8,439

5,579

Net (loss) income

$               (419,366)

$                          85,341

Basic and Diluted

 (loss) income per common share

$                    (0.01)

$                              0.00

Basic and Diluted

  average common shares outstanding

62,944,298

28,838,216

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close